Hunan Fangsheng Pharmaceutical Co., Ltd. (603998.SS)
CNY 9.6
(0.0%)
CNY 9.6
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 196.44 Million CNY | -40.84% |
| 2022 | 332.03 Million CNY | 233.06% |
| 2021 | 99.69 Million CNY | -3.43% |
| 2020 | 103.23 Million CNY | 7.14% |
| 2019 | 96.36 Million CNY | 4.65% |
| 2018 | 92.08 Million CNY | 14.81% |
| 2017 | 80.2 Million CNY | -4.5% |
| 2016 | 83.98 Million CNY | -22.87% |
| 2015 | 108.88 Million CNY | 14.62% |
| 2014 | 95 Million CNY | 11.8% |
| 2013 | 84.97 Million CNY | 12.18% |
| 2012 | 75.75 Million CNY | 27.6% |
| 2011 | 59.37 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 62.46 Million CNY | 68.31% |
| 2024 Q2 | 75.79 Million CNY | 21.35% |
| 2024 Q3 | 56.18 Million CNY | -25.87% |
| 2023 Q3 | 37.3 Million CNY | -35.33% |
| 2023 Q1 | 64.33 Million CNY | 17.06% |
| 2023 Q2 | 57.69 Million CNY | -10.32% |
| 2023 FY | 196.44 Million CNY | -40.84% |
| 2023 Q4 | 37.11 Million CNY | -0.53% |
| 2022 FY | 332.03 Million CNY | 233.06% |
| 2022 Q4 | 54.95 Million CNY | -73.99% |
| 2022 Q3 | 211.27 Million CNY | 942.79% |
| 2022 Q2 | 20.26 Million CNY | -46.03% |
| 2022 Q1 | 37.53 Million CNY | 117.3% |
| 2021 FY | 99.69 Million CNY | -3.43% |
| 2021 Q2 | 25.67 Million CNY | -15.02% |
| 2021 Q4 | 17.27 Million CNY | -34.89% |
| 2021 Q3 | 26.53 Million CNY | 3.34% |
| 2021 Q1 | 30.21 Million CNY | 23125.23% |
| 2020 Q3 | 30.07 Million CNY | 31.5% |
| 2020 Q2 | 22.86 Million CNY | 16.88% |
| 2020 Q1 | 19.56 Million CNY | 104.72% |
| 2020 FY | 103.23 Million CNY | 7.14% |
| 2020 Q4 | -131.21 Thousand CNY | -100.44% |
| 2019 FY | 96.36 Million CNY | 4.65% |
| 2019 Q1 | 29.96 Million CNY | 108.87% |
| 2019 Q2 | 36.42 Million CNY | 21.55% |
| 2019 Q3 | 20.4 Million CNY | -43.98% |
| 2019 Q4 | 9.55 Million CNY | -53.17% |
| 2018 Q2 | 30.73 Million CNY | 9.83% |
| 2018 FY | 92.08 Million CNY | 14.81% |
| 2018 Q4 | 14.34 Million CNY | -24.57% |
| 2018 Q3 | 19.02 Million CNY | -38.11% |
| 2018 Q1 | 27.98 Million CNY | 362.99% |
| 2017 Q2 | 32.44 Million CNY | 46.99% |
| 2017 Q3 | 36.32 Million CNY | 11.97% |
| 2017 Q4 | -10.63 Million CNY | -129.29% |
| 2017 FY | 80.2 Million CNY | -4.5% |
| 2017 Q1 | 22.07 Million CNY | 35.02% |
| 2016 Q4 | 16.34 Million CNY | -31.49% |
| 2016 Q3 | 23.86 Million CNY | -4.87% |
| 2016 FY | 83.98 Million CNY | -22.87% |
| 2016 Q1 | 18.69 Million CNY | -2.4% |
| 2016 Q2 | 25.08 Million CNY | 34.16% |
| 2015 Q2 | 35.81 Million CNY | 38.49% |
| 2015 Q1 | 25.85 Million CNY | 28.75% |
| 2015 FY | 108.88 Million CNY | 14.62% |
| 2015 Q4 | 19.15 Million CNY | -31.72% |
| 2015 Q3 | 28.05 Million CNY | -21.65% |
| 2014 Q3 | 25.99 Million CNY | -24.16% |
| 2014 Q1 | 14.64 Million CNY | -37.43% |
| 2014 FY | 95 Million CNY | 11.8% |
| 2014 Q2 | 34.27 Million CNY | 134.02% |
| 2014 Q4 | 20.08 Million CNY | -22.73% |
| 2013 Q4 | 23.4 Million CNY | -2.95% |
| 2013 Q3 | 24.12 Million CNY | 0.0% |
| 2013 FY | 84.97 Million CNY | 12.18% |
| 2012 FY | 75.75 Million CNY | 27.6% |
| 2011 FY | 59.37 Million CNY | 0.0% |